Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | NXC-201 |
Synonyms | |
Therapy Description |
NXC-201 is a chimeric antigen receptor (CAR)-T cell therapy targeting TNFRSF17 (BCMA), which potentially decreases tumor growth (PMID: 38768428). |